Published in EMBO J on February 17, 2005
Molecular details of cAMP generation in mammalian cells: a tale of two systems. J Mol Biol (2006) 2.05
A model of anthrax toxin lethal factor bound to protective antigen. Proc Natl Acad Sci U S A (2005) 1.58
Ratcheting up protein translocation with anthrax toxin. Protein Sci (2012) 1.38
Solution NMR structure of Apo-calmodulin in complex with the IQ motif of human cardiac sodium channel NaV1.5. J Mol Biol (2010) 1.32
Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J (2005) 1.22
Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody. Infect Immun (2009) 1.22
The adenylyl cyclase activity of anthrax edema factor. Mol Aspects Med (2009) 1.15
Cell entry and cAMP imaging of anthrax edema toxin. EMBO J (2006) 1.09
Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry (2010) 1.09
Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor. Proc Natl Acad Sci U S A (2010) 1.08
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy. Am J Respir Crit Care Med (2006) 1.08
Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides. Mol Pharmacol (2008) 1.04
Novel inhibitors of anthrax edema factor. Bioorg Med Chem (2008) 1.03
Toxin-based therapeutic approaches. Toxins (Basel) (2010) 1.00
The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog (2009) 1.00
Interactions of anthrax lethal factor with protective antigen defined by site-directed spin labeling. Proc Natl Acad Sci U S A (2011) 0.94
Electrostatic ratchet in the protective antigen channel promotes anthrax toxin translocation. J Biol Chem (2012) 0.94
A 1.3-A structure of zinc-bound N-terminal domain of calmodulin elucidates potential early ion-binding step. J Mol Biol (2007) 0.90
AB toxins: a paradigm switch from deadly to desirable. Toxins (Basel) (2010) 0.88
Mouse monoclonal antibodies to anthrax edema factor protect against infection. Infect Immun (2011) 0.88
New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis. Curr Med Chem (2011) 0.88
Bacillus anthracis edema factor substrate specificity: evidence for new modes of action. Toxins (Basel) (2012) 0.87
Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors. Toxins (Basel) (2012) 0.87
Calmodulin mediates the Ca2+-dependent regulation of Cx44 gap junctions. Biophys J (2009) 0.87
Bacillus anthracis edema toxin activates nuclear glycogen synthase kinase 3beta. Infect Immun (2008) 0.85
Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently. J Biol Chem (2008) 0.85
Activation of the edema factor of Bacillus anthracis by calmodulin: evidence of an interplay between the EF-calmodulin interaction and calcium binding. Biophys J (2010) 0.83
Dynamics and energetics: a consensus analysis of the impact of calcium on EF-CaM protein complex. Biophys J (2009) 0.82
Certhrax toxin, an anthrax-related ADP-ribosyltransferase from Bacillus cereus. J Biol Chem (2012) 0.82
Anthrax edema factor toxicity is strongly mediated by the N-end rule. PLoS One (2013) 0.82
The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05". J Bacteriol (2006) 0.81
The structure of Mlc titration factor A (MtfA/YeeI) reveals a prototypical zinc metallopeptidase related to anthrax lethal factor. J Bacteriol (2012) 0.80
Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.80
Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells. PLoS One (2011) 0.80
Structure of androcam supports specialized interactions with myosin VI. Proc Natl Acad Sci U S A (2012) 0.78
Different Roles of N-Terminal and C-Terminal Domains in Calmodulin for Activation of Bacillus anthracis Edema Factor. Toxins (Basel) (2015) 0.78
Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor. PLoS One (2013) 0.78
Empirical valence bond simulations of the chemical mechanism of ATP to cAMP conversion by anthrax edema factor. Biochemistry (2013) 0.78
Effects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema Factor. PLoS One (2015) 0.77
Structural basis of anthrax edema factor neutralization by a neutralizing antibody. Biochem Biophys Res Commun (2011) 0.77
Molecular assembly of lethal factor enzyme and pre-pore heptameric protective antigen in early stage of translocation. J Mol Model (2015) 0.76
B. anthracis Edema Toxin Increases Fractional Free Water and Sodium Reabsorption in an Isolated Perfused Rat Kidney Model. Infect Immun (2017) 0.75
The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals. Toxins (Basel) (2017) 0.75
Diminished but Not Abolished Effect of Two His351 Mutants of Anthrax Edema Factor in a Murine Model. Toxins (Basel) (2016) 0.75
A journey in science: promise, purpose, privilege. Mol Med (2013) 0.75
Defensive strategies of Bacillus anthracis that promote a fatal disease. Drug Discov Today Dis Mech (2007) 0.75
Interaction with adenylate cyclase toxin from Bordetella pertussis affects the metal binding properties of calmodulin. FEBS Open Bio (2016) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Implementation of molecular replacement in AMoRe. Acta Crystallogr D Biol Crystallogr (2001) 8.92
Anthrax toxin. Annu Rev Cell Dev Biol (2003) 5.92
Insecticidal toxins from the bacterium Photorhabdus luminescens. Science (1998) 4.35
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci U S A (1998) 4.04
A new method for predicting binding affinity in computer-aided drug design. Protein Eng (1994) 3.79
A mechanism for all polymerases. Nature (1998) 3.79
Calmodulin in action: diversity in target recognition and activation mechanisms. Cell (2002) 3.77
Crystal structure of the anthrax lethal factor. Nature (2001) 3.75
Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature (2002) 3.67
Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature (2001) 3.67
The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct (1998) 3.64
Crystal structure of a thermostable Bacillus DNA polymerase I large fragment at 2.1 A resolution. Structure (1997) 3.49
Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr Opin Struct Biol (1998) 3.31
Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc Natl Acad Sci U S A (2002) 2.51
Two-metal-Ion catalysis in adenylyl cyclase. Science (1999) 2.31
Apocalmodulin. Physiol Rev (1999) 2.30
Crystal structures of human DNA polymerase beta complexed with DNA: implications for catalytic mechanism, processivity, and fidelity. Biochemistry (1996) 2.25
Bordatella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol (1999) 2.22
Expression and characterization of calmodulin-activated (type I) adenylylcyclase. J Biol Chem (1991) 1.94
Role of toxin functional domains in anthrax pathogenesis. Infect Immun (2000) 1.93
Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med (2005) 1.90
Q: a molecular dynamics program for free energy calculations and empirical valence bond simulations in biomolecular systems. J Mol Graph Model (1999) 1.77
The class III adenylyl cyclases: multi-purpose signalling modules. Cell Signal (2003) 1.75
Target selectivity in EF-hand calcium binding proteins. Biochim Biophys Acta (2004) 1.72
Mapping the anthrax protective antigen binding site on the lethal and edema factors. J Biol Chem (2001) 1.62
A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry (2000) 1.61
Computer simulation of the chemical catalysis of DNA polymerases: discriminating between alternative nucleotide insertion mechanisms for T7 DNA polymerase. J Am Chem Soc (2003) 1.58
Structure, function and evolution of microbial adenylyl and guanylyl cyclases. Mol Microbiol (2004) 1.57
A closed compact structure of native Ca(2+)-calmodulin. Structure (2003) 1.46
Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J Biol Chem (2003) 1.43
Crystal structures of apocalmodulin and an apocalmodulin/SK potassium channel gating domain complex. Structure (2004) 1.37
Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J (2002) 1.28
Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution. J Biol Chem (2003) 1.26
The role of metal ions in RNA catalysis. Curr Opin Struct Biol (2002) 1.26
Calcium dependence of the interaction between calmodulin and anthrax edema factor. J Biol Chem (2003) 1.16
Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain. J Biol Chem (2003) 1.15
Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state. EMBO J (2001) 1.07
Convergent evolution sheds light on the anti-beta -elimination mechanism common to family 1 and 10 polysaccharide lyases. Proc Natl Acad Sci U S A (2002) 1.05
Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate. J Biol Chem (2004) 1.02
Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase. Biochemistry (1990) 0.98
The role of histidine 63 in the catalytic mechanism of Bordetella pertussis adenylate cyclase. J Biol Chem (1992) 0.97
Crystallization and preliminary X-ray study of the edema factor exotoxin adenylyl cyclase domain from Bacillus anthracis in the presence of its activator, calmodulin. Acta Crystallogr D Biol Crystallogr (2001) 0.92
Structural elucidation of the binding and inhibitory properties of lanthanide (III) ions at the 3'-5' exonucleolytic active site of the Klenow fragment. Chem Biol (1999) 0.85
Making the most of metal ions. Nat Struct Biol (2001) 0.84
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature (2002) 3.67
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature (2006) 3.21
Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol (2004) 2.58
Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol (2005) 2.45
Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med (2005) 1.90
Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'. Nat Chem Biol (2008) 1.74
DNA polymerase beta fidelity: halomethylene-modified leaving groups in pre-steady-state kinetic analysis reveal differences at the chemical transition state. Biochemistry (2007) 1.61
Modifying the beta,gamma leaving-group bridging oxygen alters nucleotide incorporation efficiency, fidelity, and the catalytic mechanism of DNA polymerase beta. Biochemistry (2007) 1.61
Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol (2005) 1.59
Double image encryption by using iterative random binary encoding in gyrator domains. Opt Express (2010) 1.55
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol (2005) 1.54
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet (2012) 1.49
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci U S A (2004) 1.46
Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell (2005) 1.45
Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem (2007) 1.44
Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J Biol Chem (2003) 1.43
Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem (2007) 1.41
Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc Natl Acad Sci U S A (2008) 1.39
Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor. Nat Biotechnol (2004) 1.37
Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb Pathog (2007) 1.36
Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS One (2010) 1.35
Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS One (2007) 1.32
Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme. Biochemistry (2008) 1.31
Simulating the effect of DNA polymerase mutations on transition-state energetics and fidelity: evaluating amino acid group contribution and allosteric coupling for ionized residues in human pol beta. Biochemistry (2006) 1.28
Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J (2002) 1.28
Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis. J Biol Chem (2009) 1.25
Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J (2005) 1.22
Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme. J Biol Chem (2009) 1.20
Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme. J Mol Biol (2009) 1.17
Calcium dependence of the interaction between calmodulin and anthrax edema factor. J Biol Chem (2003) 1.16
Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol (2011) 1.16
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. EMBO J (2010) 1.16
The adenylyl cyclase activity of anthrax edema factor. Mol Aspects Med (2009) 1.15
Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models. World J Gastroenterol (2000) 1.14
The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochem Biophys Res Commun (2006) 1.14
Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction. Front Biosci (2007) 1.11
Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA. Biochemistry (2010) 1.09
Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor. Proc Natl Acad Sci U S A (2010) 1.08
Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect (2009) 1.07
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients. J Clin Virol (2010) 1.05
Apoptosis antagonizing transcription factor protects renal tubule cells against oxidative damage and apoptosis induced by ischemia-reperfusion. J Am Soc Nephrol (2006) 1.04
Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides. Mol Pharmacol (2008) 1.04
Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides. Mol Pharmacol (2007) 1.03
A promoter recognition mechanism common to yeast mitochondrial and phage t7 RNA polymerases. J Biol Chem (2009) 1.03
Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate. J Biol Chem (2004) 1.02
Associative versus dissociative mechanisms of phosphate monoester hydrolysis: on the interpretation of activation entropies. Chemphyschem (2008) 1.02
Anthrax edema toxin sensitizes DBA/2J mice to lethal toxin. Infect Immun (2007) 1.01
Bacillus anthracis edema toxin impairs neutrophil actin-based motility. Infect Immun (2009) 1.01
Anthrax edema factor potency depends on mode of cell entry. Biochem Biophys Res Commun (2005) 0.97
Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. J Biol Chem (2011) 0.96
Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response. J Biol Chem (2010) 0.96
Decomposition of the solvation free energies of deoxyribonucleoside triphosphates using the free energy perturbation method. J Phys Chem B (2006) 0.94
Discovery of a small molecule that inhibits the interaction of anthrax edema factor with its cellular activator, calmodulin. Chem Biol (2004) 0.94
PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein. J Biol Chem (2005) 0.94
Ubiquitin is a novel substrate for human insulin-degrading enzyme. J Mol Biol (2010) 0.94
Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme. Proc Natl Acad Sci U S A (2013) 0.94
Functional architecture of T7 RNA polymerase transcription complexes. J Mol Biol (2007) 0.93
DNA duplex stability: the role of preorganized electrostatics. J Phys Chem B (2010) 0.93
Crystal structure of the F87W/Y96F/V247L mutant of cytochrome P-450cam with 1,3,5-trichlorobenzene bound and further protein engineering for the oxidation of pentachlorobenzene and hexachlorobenzene. J Biol Chem (2002) 0.92
Comparison of three anthrax toxin neutralization assays. Clin Vaccine Immunol (2010) 0.92
DNA polymerase beta catalytic efficiency mirrors the Asn279-dCTP H-bonding strength. FEBS Lett (2007) 0.92
MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1. J Transl Med (2013) 0.92
Construction of soluble adenylyl cyclase from human membrane-bound type 7 adenylyl cyclase. Methods Enzymol (2002) 0.91
Molecular mechanism of ADP-ribose hydrolysis by human NUDT5 from structural and kinetic studies. J Mol Biol (2008) 0.91
Real-time analysis of ternary complex on particles: direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction. J Biol Chem (2004) 0.90
Tunable VUV photochemistry using Rydberg H-atom time-of-flight spectroscopy. Rev Sci Instrum (2008) 0.90
Loose and strict repeats in weighted sequences of proteins. Protein Pept Lett (2010) 0.90
A Quick and Parallel Analytical Method Based on Quantum Dots Labeling for ToRCH-Related Antibodies. Nanoscale Res Lett (2009) 0.90
Expression of alpha subunit of Gs in Escherichia coli. Methods Enzymol (2002) 0.90
A 1.3-A structure of zinc-bound N-terminal domain of calmodulin elucidates potential early ion-binding step. J Mol Biol (2007) 0.90
The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor. J Virol (2007) 0.89
Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation. J Biol Chem (2009) 0.89
Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors. J Mol Biol (2007) 0.88
Probing the two-metal ion mechanism in the restriction endonuclease BamHI. Biochemistry (2007) 0.88
Sequence heterogeneity of the ORF3 gene of porcine epidemic diarrhea viruses field samples in Fujian, China, 2010-2012. Viruses (2013) 0.88
Role of expression of endothelin-1 and angiotensin-II and hypoxia-inducible factor-1α in the kidney tissues of patients with diabetic nephropathy. Saudi J Kidney Dis Transpl (2013) 0.88
Metal ion complexes of N,N'-bis(2-pyridylmethyl)-1,3-diaminopropane-N,N'-diacetic acid, H2bppd. Inorg Chem (2014) 0.86
Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification. Biochemistry (2013) 0.86
Conservation of promoter melting mechanisms in divergent regions of the single-subunit RNA polymerases. Biochemistry (2012) 0.86
The amyloid beta ion channel hypothesis of Alzheimer's disease. Neuropsychiatr Dis Treat (2007) 0.86
AATF protects neural cells against oxidative damage induced by amyloid beta-peptide. Neurobiol Dis (2004) 0.86
Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently. J Biol Chem (2008) 0.85
Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B. J Gastroenterol Hepatol (2015) 0.85
Bis-halogen-anthraniloyl-substituted nucleoside 5'-triphosphates as potent and selective inhibitors of Bordetella pertussis adenylyl cyclase toxin. J Pharmacol Exp Ther (2010) 0.85
Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues. Int J Mol Med (2008) 0.85
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α. Tumour Biol (2014) 0.85